Joseph Cappello

Insider Reports History

Entity
Individual
Location
C/O Genelux Corporation, 2625 Townsgate Road, Suite 230, Westlake Village, CA
Signature
/s/ Sean Ryder, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph Cappello:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GENELUX Corp VP, Pharmaceutical Development Common Stock 43.7K $102K $2.34 Dec 18, 2024 Direct
GENELUX Corp VP, Pharmaceutical Development Stock Option (right to buy) 39K Dec 18, 2024 Direct

Insider Reports Filed by Joseph Cappello

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GNLX GENELUX Corp Dec 18, 2024 2 $0 4 Dec 20, 2024 VP, Pharmaceutical Development
GNLX GENELUX Corp Dec 16, 2024 1 -$14.7K 4 Dec 18, 2024 VP, Pharmaceutical Development
GNLX GENELUX Corp Feb 19, 2024 2 $0 4 Jul 8, 2024 VP, Pharmaceutical Development
GNLX GENELUX Corp Sep 11, 2023 1 $0 4 Sep 12, 2023 VP, Pharmaceutical Development
GNLX GENELUX Corp Aug 18, 2023 1 -$77.5K 4 Aug 22, 2023 VP, Pharmaceutical Development
GNLX GENELUX CORP Feb 17, 2023 1 $0 4 May 2, 2023 VP, Pharmaceutical Development
GNLX GENELUX CORP Jan 25, 2023 0 $0 3 Jan 25, 2023 VP, Pharmaceutical Development